Literature DB >> 28233656

Initial Session Duration and Mortality Among Incident Hemodialysis Patients.

Shailender Swaminathan1, Vincent Mor2, Rajnish Mehrotra3, Amal N Trivedi2.   

Abstract

BACKGROUND: The association of dialysis session duration with mortality in patients undergoing maintenance hemodialysis is unclear. We compared mortality rates of patients treated in dialysis facilities that used initial session durations of either ≥ 4 versus 3 hours for all incident patients. STUDY
DESIGN: Retrospective cohort study. SETTINGS & PARTICIPANTS: Patients with end-stage renal disease beginning maintenance hemodialysis therapy in January 2006 to December 2010 and followed up through December 2012, including 39,172 patients in 852 facilities who initiated treatment for ≥ 4 hours and 47,721 patients in 631 facilities who initiated treatment for 3 hours. PREDICTOR: Initial session duration of ≥ 4 hours versus 3 hours. OUTCOME: 2- and 1-year mortality rates.
RESULTS: Total numbers of deaths observed within 2 years after initiating dialysis therapy were 8,945 in the ≥ 4-hour group and 15,624 in the 3-hour group. The corresponding numbers of deaths observed within 1 year were 5,492 and 10,372, respectively. The 2-year adjusted HR in the ≥ 4-hour versus 3-hour group was 0.79 (95% CI, 0.73-0.86). The corresponding 1-year adjusted HR was 0.77 (95% CI, 0.70-0.84). Results were robust when analyses were restricted to specific subgroups of patients classified by age, sex, race, and select clinical characteristics. LIMITATIONS: We did not observe hemodialysis duration in sessions subsequent to initiation. We only included patients treated in facilities with uniform session length (at initiation) for all their patients. Furthermore, we lacked information for dialysis dosage and patients' baseline residual kidney function.
CONCLUSIONS: Patients in facilities routinely initiating hemodialysis therapy for ≥ 4 hours may have substantially lower mortality as compared with patients in facilities initiating for only 3 hours of treatment.
Copyright © 2017 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Renal hemodialysis; death; end-stage renal disease (ESRD); facility-level analysis; mortality rate; quasi-experimental design; session length, dialysis duration, dialysis facilities; treatment time

Mesh:

Year:  2017        PMID: 28233656      PMCID: PMC5695674          DOI: 10.1053/j.ajkd.2016.11.017

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

1.  Dialysis Outcomes and Practice Patterns Study (DOPPS): its strengths, limitations, and role in informing practices and policies.

Authors:  Bruce M Robinson; Brian Bieber; Ronald L Pisoni; Friedrich K Port
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-25       Impact factor: 8.237

2.  Dialysis time, survival, and dose-targeting bias.

Authors:  John T Daugirdas
Journal:  Kidney Int       Date:  2013-01       Impact factor: 10.612

3.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Authors:  R Saran; J L Bragg-Gresham; N W Levin; Z J Twardowski; V Wizemann; A Saito; N Kimata; B W Gillespie; C Combe; J Bommer; T Akiba; D L Mapes; E W Young; F K Port
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

4.  Dose of hemodialysis and survival: differences by race and sex.

Authors:  W F Owen; G M Chertow; J M Lazarus; E G Lowrie
Journal:  JAMA       Date:  1998-11-25       Impact factor: 56.272

5.  Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.

Authors:  Steven M Brunelli; Glenn M Chertow; Elizabeth D Ankers; Edmund G Lowrie; Ravi Thadhani
Journal:  Kidney Int       Date:  2010-01-20       Impact factor: 10.612

6.  Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Authors:  Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert Toto
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

7.  Association of hemodialysis treatment time and dose with mortality and the role of race and sex.

Authors:  Jessica E Miller; Csaba P Kovesdy; Allen R Nissenson; Rajnish Mehrotra; Elani Streja; David Van Wyck; Sander Greenland; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2009-10-22       Impact factor: 8.860

8.  Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study.

Authors:  E G Lowrie; N M Laird; T F Parker; J A Sargent
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

9.  Shorter length dialysis sessions are associated with increased mortality, independent of body weight.

Authors:  Jennifer E Flythe; Gary C Curhan; Steven M Brunelli
Journal:  Kidney Int       Date:  2012-09-26       Impact factor: 10.612

10.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2013-09-30       Impact factor: 2.373

View more
  3 in total

1.  Impact of residual kidney function on hemodialysis adequacy and patient survival.

Authors:  Mengjing Wang; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Jing Chen; Chuanming Hao; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

2.  Survival and predictors of mortality among chronic kidney disease patients on hemodialysis in Amhara region, Ethiopia, 2021.

Authors:  Sewnet Getaye Workie; Taye Abuhay Zewale; Gizachew Tadesse Wassie; Makda Abate Belew; Eleni Dagnaw Abeje
Journal:  BMC Nephrol       Date:  2022-05-23       Impact factor: 2.585

3.  Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.

Authors:  Giorgina Barbara Piccoli; Louise Nielsen; Lurilyn Gendrot; Antioco Fois; Emanuela Cataldo; Gianfranca Cabiddu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.